Zevra Therapeutics, Inc. (ZVRA)
8.45
-0.13
(-1.52%)
USD |
NASDAQ |
Dec 10, 16:00
8.34
-0.11
(-1.30%)
Pre-Market: 08:03
Zevra Therapeutics Total Assets (Quarterly): 270.12M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Nektar Therapeutics | 301.35M |
| XOMA Royalty Corp. | 263.15M |
| Akebia Therapeutics, Inc. | 364.15M |
| NovaBay Pharmaceuticals, Inc. | 3.487M |
| Palatin Technologies, Inc. | 8.615M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 136.95M |
| Shareholders Equity (Quarterly) | 133.16M |
| Debt to Equity Ratio | 0.471 |
| Current Ratio | 8.621 |
| Net Debt Paydown Yield | -0.12% |